Neuroscience Bulletin,
Год журнала:
2021,
Номер
37(10), С. 1510 - 1522
Опубликована: Июль 3, 2021
Abstract
Many
recent
studies
have
shown
that
the
gut
microbiome
plays
important
roles
in
human
physiology
and
pathology.
Also,
microbiome-based
therapies
been
used
to
improve
health
status
treat
diseases.
In
addition,
aging
neurodegenerative
diseases,
including
Alzheimer's
disease
Parkinson's
disease,
become
topics
of
intense
interest
biomedical
research.
Several
researchers
explored
links
between
these
study
potential
pathogenic
or
therapeutic
effects
intestinal
microbiota
disease.
But
exact
relationship
diseases
remains
unclear.
As
technology
advances,
new
techniques
for
studying
will
be
developed
refined,
revealed.
This
article
summarizes
known
interactions
highlighting
assay
microbiome,
we
also
discuss
role
Acta Pharmaceutica Sinica B,
Год журнала:
2019,
Номер
10(3), С. 475 - 487
Опубликована: Июль 7, 2019
ProBiotic-4
is
a
probiotic
preparation
composed
of
Bifidobacterium
lactis,
Lactobacillus
casei,
bifidum,
and
acidophilus.
This
study
aims
to
investigate
the
effects
on
microbiota-gut-brain
axis
cognitive
deficits,
explore
underlying
molecular
mechanism
using
senescence-accelerated
mouse
prone
8
(SAMP8)
mice.
was
orally
administered
9-month-old
SAMP8
mice
for
12
weeks.
We
observed
that
significantly
improved
memory
cerebral
neuronal
synaptic
injuries,
glial
activation,
microbiota
composition
in
feces
brains
aged
substantially
attenuated
aging-related
disruption
intestinal
barrier
blood-brain
barrier,
decreased
interleukin-6
tumor
necrosis
factor-α
at
both
mRNA
protein
levels,
reduced
plasma
lipopolysaccharide
(LPS)
concentration,
toll-like
receptor
4
(TLR4)
expression,
nuclear
factor-κB
(NF-κB)
translocation
brain.
In
addition,
not
only
did
levels
γ-H2AX,
8-hydroxydesoxyguanosine,
retinoic-acid-inducible
gene-I
(RIG-I),
it
also
abrogated
RIG-I
multimerization
These
findings
suggest
targeting
gut
with
probiotics
may
have
therapeutic
potential
deficits
function
aging,
its
associated
inhibition
TLR4-and
RIG-I-mediated
NF-κB
signaling
pathway
inflammatory
responses.
World Journal of Gastroenterology,
Год журнала:
2022,
Номер
28(30), С. 4053 - 4060
Опубликована: Авг. 9, 2022
The
gut
microbiota
is
a
complex
community
of
microorganisms
that
inhabit
the
digestive
tracts
humans,
living
in
symbiosis
with
host.
Dysbiosis,
characterized
by
an
imbalance
between
beneficial
and
opportunistic
microbiota,
associated
several
gastrointestinal
disorders,
such
as
irritable
bowel
syndrome
(IBS);
inflammatory
disease
(IBD),
represented
ulcerative
colitis
Crohn's
disease;
colorectal
cancer
(CRC).
Dysbiosis
can
disrupt
mucosal
barrier,
resulting
perpetuation
inflammation
carcinogenesis.
increase
some
specific
groups
harmful
bacteria,
Escherichia
coli
(E.
coli)
enterotoxigenic
Bacteroides
fragilis
(ETBF),
has
been
chronic
tissue
release
pro-inflammatory
carcinogenic
mediators,
increasing
chance
developing
CRC,
following
inflammation-dysplasia-cancer
sequence
IBD
patients.
Therefore,
aim
present
review
was
to
analyze
correlation
changes
development
maintenance
IBD,
IBD-associated
CRC.
Patients
CRC
have
shown
reduced
bacterial
diversity
abundance
compared
healthy
individuals,
enrichment
Firmicute
sand
Bacteroidetes.
Specific
bacteria
are
also
onset
progression
Fusobacterium
nucleatum,
E.
coli,
Enterococcus
faecalis,
Streptococcus
gallolyticus,
ETBF.
Future
research
evaluate
advantages
modulating
preventive
measures
high-risk
patients,
directly
affecting
prognosis
quality
life
Nutrients,
Год журнала:
2020,
Номер
13(1), С. 37 - 37
Опубликована: Дек. 24, 2020
For
years,
it
has
been
reported
that
Alzheimer’s
disease
(AD)
is
the
most
common
cause
of
dementia.
Various
external
and
internal
factors
may
contribute
to
early
onset
AD.
This
review
highlights
a
contribution
disturbances
in
microbiota–gut–brain
(MGB)
axis
development
Alteration
gut
microbiota
composition
determined
by
increase
permeability
barrier
immune
cell
activation,
leading
impairment
blood–brain
function
promotes
neuroinflammation,
neuronal
loss,
neural
injury,
ultimately
Numerous
studies
have
shown
plays
crucial
role
brain
changes
behavior
individuals
formation
bacterial
amyloids.
Lipopolysaccharides
amyloids
synthesized
can
trigger
cells
residing
activate
response
neuroinflammation.
Growing
experimental
clinical
data
indicate
prominent
dysbiosis
microbiota–host
interactions
Modulation
with
antibiotics
or
probiotic
supplementation
create
new
preventive
therapeutic
options
Accumulating
evidences
affirm
research
on
MGB
involvement
AD
necessary
for
treatment
targets
therapies
Molecular Neurodegeneration,
Год журнала:
2022,
Номер
17(1)
Опубликована: Март 5, 2022
The
implication
of
gut
microbiota
in
the
control
brain
functions
health
and
disease
is
a
novel,
currently
emerging
concept.
Accumulating
data
suggest
that
exert
its
action
at
least
part
by
modulating
neuroinflammation.
Given
link
between
neuroinflammatory
changes
neuronal
activity,
it
plausible
may
affect
indirectly
impacting
microglia,
key
player
Indeed,
increasing
evidence
suggests
interplay
microglia
synaptic
dysfunction
involve
microbiota,
among
other
factors.
In
addition
to
these
indirect
microglia-dependent
actions
on
has
been
recently
recognized
could
also
activity
directly
stimulation
vagus
nerve.
European Journal of Neuroscience,
Год журнала:
2019,
Номер
53(1), С. 222 - 235
Опубликована: Дек. 2, 2019
Major
depressive
disorder
(MDD)
is
a
psychiatric
condition
that
affects
large
number
of
people
in
the
world,
and
treatment
existents
do
not
work
for
all
individuals
affected.
Thus,
it
believed
other
systems
or
pathways
which
regulate
brain
networks
involved
mood
regulation
cognition
are
associated
with
MDD
pathogenesis.
Studies
humans
animal
models
have
been
shown
there
increased
levels
inflammatory
mediators,
including
cytokines
chemokines
both
periphery
central
nervous
system
(CNS).
In
addition,
microglial
activation
appears
to
be
key
event
triggers
changes
signaling
cascades
gene
expression
would
determinant
onset
symptoms.
Recent
researches
also
point
out
gut
microbiota
lead
systemic
inflammation
different
ways
reach
CNS
modulating
especially
microglia,
could
influence
responses
treatments.
Moreover,
pre-
probiotics
antidepressant
anti-inflammatory
effects.
This
review
will
focus
on
studies
show
relationship
microbiota-brain
axis
its
relation
MDD.
Abstract
Background
Gut
microbiota
plays
an
important
role
in
physiological
and
pathological
processes
of
the
host
organism,
including
aging.
Microbiota
composition
was
shown
to
vary
significantly
throughout
life
course.
Age-related
changes
were
reported
several
human
studies.
In
present
study,
age-related
dynamics
phylogenetic
profile
gut
investigated
1550
healthy
participants
from
Ukrainian
population.
Results
Significant
determined
by
qRT-PCR
at
level
major
microbial
phyla
across
age
groups
have
been
observed.
The
relative
abundance
Actinobacteria
Firmicutes
increased,
while
that
Bacteroidetes
decreased
childhood
elderly
age.
Accordingly,
Firmicutes/Bacteroidetes
(F/B)
ratio
increase
until
elder
both
sexes,
odds
F/B
>
1
tended
with
age,
reaching
maximum
values
[OR
=
2.7
(95%
CI,
1.2–6.0)
OR
3.7
1.4–9.6)
for
female
male
60–69-year
groups,
respectively,
compared
same-sex
reference
(0–9-year)
groups].
Conclusions
conclusion,
data
our
study
indicate
intestinal
differs
groups.
tends
0–9-year
Further
studies
are
needed
a
better
understanding
mechanisms
underlying
composition.
Brain Communications,
Год журнала:
2020,
Номер
2(2)
Опубликована: Янв. 1, 2020
Huntington's
disease
is
characterized
by
a
triad
of
motor,
cognitive
and
psychiatric
impairments,
as
well
unintended
weight
loss.
Although
much
the
research
has
focused
on
cognitive,
motor
symptoms,
extent
peripheral
pathology
relationship
between
these
factors,
core
symptoms
disease,
are
relatively
unknown.
Gut
microbiota
key
modulators
communication
brain
gut,
alterations
in
composition
(dysbiosis)
can
negatively
affect
cognition,
behaviour
affective
function,
may
be
implicated
progression.
Furthermore,
gut
dysbiosis
was
recently
reported
transgenic
mice.
Our
main
objective
to
characterize
microbiome
people
with
determine
whether
significantly
related
clinical
indicators
We
compared
42
gene
expansion
carriers,
including
19
who
were
diagnosed
(Total
Functional
Capacity
>
6)
23
premanifest
stage,
36
age-
gender-matched
healthy
controls.
Participants
clinically
using
battery
tests
results
from
16S
V3
V4
rRNA
sequencing
faecal
samples
microbiome.
For
measures,
we
found
significant
differences
microbial
communities
(beta
diversity)
based
unweighted
UniFrac
distance
(P
=
0.001),
lower
alpha
diversity
(species
richness
evenness)
our
combined
carrier
group
controls
0.001).
also
major
shifts
community
structure
at
Phylum
Family
levels,
identified
functional
pathways
enzymes
affected
group.
Within
group,
discovered
associations
among
bacteria,
performance
outcomes.
Overall,
findings
suggest
an
altered
carriers.
These
highlight
importance
biomarkers
raise
interesting
questions
regarding
role
it
potential
target
for
future
therapeutic
intervention.
ACS Chemical Neuroscience,
Год журнала:
2023,
Номер
14(10), С. 1717 - 1763
Опубликована: Май 8, 2023
Gut
microbiota
includes
a
vast
collection
of
microorganisms
residing
within
the
gastrointestinal
tract.
It
is
broadly
recognized
that
gut
and
brain
are
in
constant
bidirectional
communication,
which
its
metabolic
production
major
component,
form
so-called
microbiome–brain
axis.
Disturbances
homeostasis
caused
by
imbalance
their
functional
composition
activities,
known
as
dysbiosis,
cause
dysregulation
these
pathways
trigger
changes
blood–brain
barrier
permeability,
thereby
causing
pathological
malfunctions,
including
neurological
disorders.
In
turn,
can
affect
structure
function
through
autonomic
nervous
system
regulating
motility,
intestinal
transit
secretion,
permeability.
Here,
we
examine
data
from
CAS
Content
Collection,
largest
published
scientific
information,
analyze
publication
landscape
recent
research.
We
review
advances
knowledge
related
to
human
microbiome,
complexity
functionality,
communication
with
central
system,
effect
axis
on
mental
health.
discuss
correlations
between
various
diseases,
specifically
also
explore
metabolites
regard
impact
associated
diseases.
Finally,
assess
clinical
applications
gut-microbiota-related
substances
development
pipelines.
hope
this
serve
useful
resource
understanding
current
emerging
field
an
effort
further
solving
remaining
challenges
fulfilling
potential.
Translational Neurodegeneration,
Год журнала:
2022,
Номер
11(1)
Опубликована: Июнь 4, 2022
Abstract
Most
neurodegenerative
disorders
are
diseases
of
protein
homeostasis,
with
misfolded
aggregates
accumulating.
The
process
is
mediated
by
numerous
metabolic
pathways,
most
which
lead
to
apoptosis.
In
recent
years,
hydrophilic
bile
acids,
particularly
tauroursodeoxycholic
acid
(TUDCA),
have
shown
important
anti-apoptotic
and
neuroprotective
activities,
experimental
clinical
evidence
suggesting
their
possible
therapeutic
use
as
disease-modifiers
in
diseases.
Experimental
on
the
mechanisms
underlying
TUDCA’s
action
derives
from
animal
models
Alzheimer’s
disease,
Parkinson’s
Huntington’s
diseases,
amyotrophic
lateral
sclerosis
(ALS)
cerebral
ischemia.
Preclinical
studies
indicate
that
TUDCA
exerts
its
effects
not
only
regulating
inhibiting
apoptotic
cascade,
but
also
reducing
oxidative
stress,
protecting
mitochondria,
producing
an
anti-neuroinflammatory
action,
acting
a
chemical
chaperone
maintain
stability
correct
folding
proteins.
Furthermore,
data
phase
II
trials
be
safe
potential
disease-modifier
ALS.
ALS
first
disease
being
treated
acids.
While
further
accumulated
for
other
stands
promising
treatment